People are becoming increasingly interested in classic psychedelics as potential interventions to treat a range of mental health conditions. Psilocybin is a classic psychedelic that is showing promising results in...
On Wednesday, April 6, 2022, Kerry J. Ressler, MD, PhD, Chief Scientific Officer at McLean Hospital and Professor of Psychiatry at Harvard Medical School, will present a Psychiatry Grand Rounds...
Even under the best of circumstances, giving birth can be physically and emotionally challenging. But for some women, the experience can be so traumatic that it affects their mental health...
Utah authorizes a state-funded clinical trial studying psychedelic-assisted therapy for veterans with treatment-resistant PTSD, marking a cautious, evidence-first approach to psychedelic research. HB390 is a necessary first-step, and lays the...
